T
CHMT

Tahithromos’s Chemtura Corporation CHMT Stock Holding History

Tahithromos’s Portfolio CHMT Stock Details CHMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-277,999
Closed -$6.49M – 47
2014
Q3 		$6.49M Buy
277,999
+176,999
+175% +$4.39M 1.68% 20
2014
Q2 		$2.64M Buy
+101,000
New +$2.49M 0.63% 33

Other funds holding CHMT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
KAM
Keeley Asset Management Chicago, Illinois $2.35B AUM 26.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Tahithromos's CHMT Position: Q4 2014 in Review

Tahithromos sold out of Chemtura Corporation (CHMT) in Q4 2014, closing a stake of 277,999 shares — an estimated $6.49M sold.

Tahithromos first reported a position in CHMT in Q2 2014 and held it in 2 quarters. The position peaked at $6.49M in Q3 2014. 161 funds tracked by Wall St. Rank hold CHMT as of Q4 2014.

  • Tahithromos reported no remaining Chemtura Corporation position as of Q4 2014 after selling out during the quarter.
  • Tahithromos sold 277,999 Chemtura Corporation shares in Q4 2014, an estimated $6.49M.
  • Tahithromos first reported a position in Chemtura Corporation in Q2 2014 and held it in 2 quarters.
  • Tahithromos's Chemtura Corporation position peaked at $6.49M in Q3 2014.
  • 161 funds tracked by Wall St. Rank held Chemtura Corporation as of Q4 2014.

Based on Tahithromos's 13F filing for Q4 2014, filed 22 Jan 2015.